MiR-351 transiently increases during muscle regeneration and promotes progenitor cell proliferation and survival upon differentiation
about
Noncoding RNAs, Emerging Regulators of Skeletal Muscle Development and DiseasesFrom Nutrient to MicroRNA: a Novel Insight into Cell Signaling Involved in Skeletal Muscle Development and DiseasePreparation of primary myogenic precursor cell/myoblast cultures from basal vertebrate lineagesIdentifying microRNAs involved in aging of the lateral wall of the cochlear ductIntegrative analysis of porcine microRNAome during skeletal muscle development.Temporal analysis of reciprocal miRNA-mRNA expression patterns predicts regulatory networks during differentiation in human skeletal muscle cells.miR-487b, miR-3963 and miR-6412 delay myogenic differentiation in mouse myoblast-derived C2C12 cells.Uvrag targeting by Mir125a and Mir351 modulates autophagy associated with Ewsr1 deficiencyMicroRNA-351 Regulates Two-Types of Cell Death, Necrosis and Apoptosis, Induced by 5-fluoro-2'-deoxyuridineMicroRNA expression patterns in post-natal mouse skeletal muscle development.The role of microRNAs in skeletal muscle health and diseaseMicroRNAs in skeletal muscle biology and exercise adaptation.The miR-125 family is an important regulator of the expression and maintenance of maternal effect genes during preimplantational embryo development.MicroRNA in myogenesis and muscle atrophySpecies-specific microRNA regulation influences phenotypic variability: perspectives on species-specific microRNA regulation.Regulation of Skeletal Muscle by microRNAs.Role of microRNA-27a in myoblast differentiation.Prognostic role of microRNA-221 in various human malignant neoplasms: a meta-analysis of 20 related studiesMicroRNA-351 inhibits denervation-induced muscle atrophy by targeting TRAF6Absence of CCR2 results in an inflammaging environment in young mice with age-independent impairments in muscle regeneration.MiR-351 negatively regulates osteoblast differentiation of MSCs induced by (+)-cholesten-3-one through targeting VDR.Characterization of extracellular vesicles derived from cardiac cells in an in vitro model of preconditioning.
P2860
Q26799919-4A8F6CF9-E4E3-45CF-B1D5-76E7B3753735Q28080060-CDF6B159-8AAD-4759-ADF7-A4BB80D6DFC5Q34060057-783A38F4-411C-4A24-86E3-0255BE5A2199Q34535461-269BFBAD-D306-44D3-8535-771A95695FA4Q34988387-6F7053BE-AA10-48D9-A3F8-7CA101AF8AE1Q35138461-714E5624-EE10-4C96-A516-8C33CFD4CD40Q35618210-DB9DCCA2-D6CC-489D-B989-073C3D5415FFQ35871511-A1ED5A5E-3CB3-41F9-A723-714B3F980A6FQ35987397-6729CCAD-2282-4FE4-A736-6406D3022DA4Q36243045-39DA2DB2-C15D-4A6F-B092-105FF055F0BEQ36860334-59E78FD9-1281-4591-B6F7-FB23D13E3DADQ36902753-C6056D1B-933A-4DB0-AA8C-D29820EA2AABQ37464136-6FF77B67-EF8A-41FF-A227-779DB5552DE8Q37667054-C0CB998A-8D83-47C2-B733-57EE361A9E74Q38122334-7C35CCB7-2925-41A0-A905-9564D33D9858Q38878232-38564692-2413-406E-860F-6CF6281052BBQ39079344-6B06B328-D069-4ACA-88D9-F976399262BEQ39261238-38EFB1AB-778F-4481-8B1B-46D8DAF9251AQ41398425-9E110C81-6B95-4126-B722-B7F19ABAC0A7Q42707203-6B9FB7A2-A70E-4869-98B1-4B933E9BB63EQ47161475-EE41E0ED-C41D-4909-9FA5-38A1062E2ED9Q50351165-5E6BA68F-1DC4-4801-A421-A32E18C44F5B
P2860
MiR-351 transiently increases during muscle regeneration and promotes progenitor cell proliferation and survival upon differentiation
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
MiR-351 transiently increases ...... survival upon differentiation
@ast
MiR-351 transiently increases ...... survival upon differentiation
@en
type
label
MiR-351 transiently increases ...... survival upon differentiation
@ast
MiR-351 transiently increases ...... survival upon differentiation
@en
prefLabel
MiR-351 transiently increases ...... survival upon differentiation
@ast
MiR-351 transiently increases ...... survival upon differentiation
@en
P2093
P2860
P1476
MiR-351 transiently increases ...... survival upon differentiation
@en
P2093
David W Melton
Jonathan A L Gelfond
Linda M McManus
Paula K Shireman
Yongxin Chen
P2860
P304
P356
10.1152/PHYSIOLGENOMICS.00052.2012
P577
2012-09-11T00:00:00Z